Device Trial Radar · NCT01914302
The Characterization of Blood Volumes of Commercially Available Lancing Devices
Last checked: Nov 19, 2026Latest source record: Aug 2, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
64
Actual
Start
Jul 2013
Primary completion
Jul 2013
Study completion Jul 2013
Sponsor
- Lead sponsor
- Facet TechnologiesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- LifeScan
- First posted
- Aug 2, 2013
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Characterize expressed blood volume ≥1μL across representative, commercially available lancing device systems using finger sticks.
Conditions
- Diabetes
Interventions
Delica Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Flash Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Easy Touch Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Glucoject Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Microlet Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Multiclix Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Fastclix Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Reli-On Lancing DeviceDevice
Characterize Blood Volume and Pain under normal use circumstances
Primary outcomes
What the sponsor says the trial is designed to measure.
- Blood Volumes measured in microlitersTime frame: between 1 and 10 days after first visit
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Facet Technologies
Kennesaw, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.